Theravance Biopharma EPS Basic from Discontinued Operations (Quarterly) Trends

Theravance Biopharma, Inc. (TBPH)

20.39 +0.06 (+0.30%) USD | NASDAQ | Jan 14, 12:29

View EPS Basic from Discontinued Operations (Quarterly) for TBPH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Discontinued Operations (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	--
Kyntra Bio, Inc.	Upgrade
Myomo, Inc.	--